commentari
lower
respiratori
tract
infect
lead
caus
death
hematopoiet
cellular
transplant
recipi
microbiolog
etiolog
infect
frequent
unknown
limit
current
diagnost
preclud
target
antimicrobi
treatment
result
excess
morbid
mortal
metagenom
nextgener
sequenc
may
enabl
precis
diagnosi
respiratori
infect
hematopoiet
cellular
transplant
patient
simultan
detect
microbi
pathogen
transcript
biomark
host
respons
pulmonari
microbiom
approach
may
facilit
target
antimicrobi
prescript
provid
new
method
distinguish
infecti
noninfecti
posttranspl
respiratori
ill
abstract
rational
current
microbiolog
diagnost
often
fail
identifi
etiolog
lower
respiratori
tract
infect
lrti
hematopoiet
cellular
transplant
recipi
hct
preclud
implement
target
therapi
object
address
need
improv
lrti
diagnost
evalu
util
metagenom
next
gener
sequenc
mng
bronchoalveolar
lavag
bal
detect
microbi
pathogen
hct
patient
acut
respiratori
ill
method
enrol
posthct
adult
age
year
acut
respiratori
ill
underw
bal
univers
michigan
januari
may
mng
perform
bal
fluid
detect
microb
simultan
assess
host
transcript
respons
result
compar
convent
microbiolog
assay
measur
main
result
mng
demonstr
sensit
detect
respiratori
microb
human
metapneumoviru
respiratori
syncyti
viru
stenotrophomona
maltophilia
human
herpesviru
cytomegaloviru
compar
standard
test
previous
unrecogn
lrti
pathogen
identifi
six
patient
standard
test
neg
human
coronaviru
human
rhinoviru
corynebacterium
propinquum
streptococcu
miti
find
confirm
independ
pcr
rrna
sequenc
rel
patient
without
infect
patient
infect
increas
express
immun
relat
gene
significantli
lower
divers
respiratori
microbiom
compar
convent
diagnost
mng
enhanc
detect
pathogen
bal
fluid
hct
patient
furthermor
result
suggest
combin
unbias
microbi
pathogen
detect
assess
host
gene
biomark
immun
respons
may
hold
promis
enhanc
diagnosi
posthct
respiratori
infect
abstract
word
count
lower
respiratori
tract
infect
lrti
lead
reason
hospit
mortal
hematopoiet
cellular
transplant
hct
recipi
problem
underscor
autopsi
studi
show
previous
undetect
pulmonari
pathogen
may
contribut
death
hct
recipi
despit
etiolog
pathogen
remain
unidentifi
case
lrti
due
larg
limit
current
microbiolog
test
term
sensit
speed
breadth
assay
target
diagnosi
lrti
hct
recipi
particularli
challeng
due
high
rate
noninfecti
inflammatori
condit
graft
versu
host
diseas
gvhd
drive
pulmonari
inflamm
induc
fever
mimic
infect
furthermor
diagnost
yield
tradit
test
reduc
hct
patient
due
antimicrobi
prophylaxi
reduc
antibodi
titer
infect
uncommon
opportunist
microorgan
limit
current
microbiolog
test
drive
excess
use
empir
broadspectrum
antimicrobi
potenti
emerg
drug
resist
increas
risk
clostridium
difficil
infect
situat
empir
regimen
may
lack
activ
underli
microb
lead
treatment
failur
diseas
progress
consequ
advers
outcom
furthermor
transplant
patient
concern
gvhd
may
compel
clinician
initi
empir
immunosuppress
agent
could
inadvert
exacerb
diseas
presenc
unrecogn
infect
previous
microarray
approach
prove
use
broaden
scope
pathogen
detect
singl
lrti
assay
microarray
even
incorpor
conserv
sequenc
known
virus
allow
detect
novel
viral
strain
metagenom
nextgener
sequenc
mng
inher
offer
enhanc
diagnost
capabl
provid
cultureindepend
comprehens
measur
microbi
composit
clinic
sampl
technolog
permit
simultan
detect
bacteri
viral
fungal
pathogen
without
introduc
bia
associ
fixedtarget
pcr
serolog
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
assay
captur
microbi
human
rna
mng
also
permit
simultan
transcript
profil
host
immunolog
respons
provid
complementari
insight
regard
presenc
type
infect
due
clear
need
enhanc
respiratori
pathogen
diagnost
hct
recipi
undertook
studi
examin
util
hostpathogen
mng
detect
lrti
pathogen
hct
patient
hospit
acut
respiratori
ill
retrospect
studi
evalu
sequenti
enrol
adult
hct
recipi
underw
bronchoscopi
bronchoalveolar
lavag
bal
univers
michigan
medic
center
januari
th
may
th
patient
met
establish
clinic
definit
communityacquir
hospitalacquir
pneumonia
two
follow
cough
fever
chill
dyspnea
pleurit
chest
pain
crackl
bronchial
breath
addit
opac
infiltr
nodul
chest
radiograph
requir
total
nucleic
acid
extract
patient
bal
fluid
use
beadbas
lysi
zymo
viral
dnarna
kit
zymo
research
rna
dna
isol
separ
use
dnase
rnase
respect
former
revers
transcrib
gener
complementari
dna
cdna
dna
cdna
underw
adapt
addit
barcod
use
nextera
system
illumina
deplet
abund
sequenc
hybrid
dash
employ
select
deplet
human
mitochondri
cdna
thu
enrich
microbi
transcript
final
rnaseq
dna
sequenc
dnaseq
librari
underw
nucleotid
pairedend
illumina
sequenc
methodolog
describ
onlin
data
supplement
detect
microbi
pathogen
leverag
custom
bioinformat
pipelin
discrimin
pathogen
background
microbi
sequenc
clinic
sampl
methodolog
detail
onlin
data
supplement
briefli
analyt
approach
involv
first
filter
qualiti
complex
next
extract
sequenc
align
human
pan
troglodyt
genom
ncbi
grc
ucsc
use
star
subsequ
remov
read
align
nonfung
eukaryot
phage
use
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
ident
remain
read
determin
queri
ncbi
nucleotid
nt
nonredund
protein
nr
databas
use
gsnapl
mitig
spuriou
taxonom
assign
due
laboratori
background
contamin
calcul
standard
zscore
microbi
genu
rel
control
group
notempl
wateronli
control
detail
tabl
deriv
sequenc
run
perform
laboratori
past
year
zscore
calcul
base
uniqu
read
align
either
ncbi
nt
nr
per
million
sequenc
input
read
rpm
nt
rpm
nr
respiratori
tract
steril
environ
devis
rank
score
aid
stratif
inher
complex
align
data
metric
involv
multipli
number
read
align
per
million
read
sequenc
sum
nt
nr
zscore
microbi
genu
identifi
patient
score
rpm
nt
x
z
nt
z
nr
improv
specif
microbi
assign
requir
microb
detect
nucleotid
nt
protein
nr
databas
align
microb
z
nt
z
nr
zero
bacteria
fungi
detect
rnaseq
also
detect
genom
sequenc
dnaseq
addit
permit
dna
virus
detect
dnaseq
rna
virus
detect
rnaseq
patient
microb
pass
requir
process
use
follow
decis
tree
summar
figur
microb
consid
confirm
pathogen
clinic
test
mng
identifi
microb
b
exist
literatur
evid
microbi
pathogen
lung
c
microb
score
least
twofold
greater
microb
type
viru
bacteria
fungu
identifi
patient
microb
consid
new
potenti
pathogen
mng
alon
identifi
microb
b
exist
literatur
evid
microbi
pathogen
lung
c
microb
score
twofold
greater
microb
type
viru
bacteria
fungu
patient
new
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
page
potenti
pathogen
confirm
independ
specif
pcr
test
virus
rrna
gene
sanger
sequenc
bacteria
final
microb
consid
unlik
uncertain
pathogen
lack
robust
literatur
evid
microbi
pathogen
lung
b
score
less
twofold
toprank
microb
suggest
polymicrobi
sampl
c
determin
clinic
insignific
treatment
team
dna
viru
uncertain
pathogen
present
low
abund
alpha
divers
respiratori
microbiom
subject
assess
use
simpson
divers
index
sdi
compar
patient
confirm
pathogen
b
unlik
uncertain
pathogen
c
new
potenti
pathogen
use
nonparametr
wilcoxon
rank
sum
test
rna
transcript
align
human
genom
captur
comput
pipelin
describ
cumul
sum
scale
normal
proteincod
gene
transcript
carri
gene
express
fewer
sampl
outlier
sampl
remov
use
supervis
approach
pathway
relat
immun
function
select
priori
molecular
signatur
databas
compar
term
total
normal
express
subject
use
nonparametr
wilcoxon
rank
sum
test
describ
onlin
data
supplement
pathway
contain
gene
biomark
associ
antivir
respons
interferon
signal
adapt
immun
strongli
associ
immun
respons
infect
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
page
enrol
hct
recipi
hospit
acut
respiratori
symptom
age
year
median
day
posttranspl
summar
tabl
common
transplant
indic
leukemia
lymphoma
major
patient
receiv
allogen
hct
andor
myeloabl
condit
summar
tabl
median
absolut
neutrophil
count
anc
time
bal
iqr
studi
subject
receiv
antimicrobi
prophylaxi
prior
symptom
onset
bronchoscopi
empir
broad
spectrum
antibiot
use
patient
includ
vancomycin
cefepim
vancomycin
cefepim
cefepim
tobramycin
vancomycin
cefepim
tobramycin
tabl
pathogentarget
antimicrobi
use
three
subject
four
patient
receiv
antimicrobi
asid
preexist
prophylact
agent
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
page
standard
care
clinic
bal
diagnost
perform
studi
hospit
describ
method
identifi
microb
seven
patient
six
thought
repres
etiolog
pathogen
treat
physician
includ
hmpv
rsv
stenotrophomona
maltophilia
cmv
identifi
shell
vial
cultur
subject
thought
repres
incident
carriag
symptom
resolut
absenc
intervent
prior
return
test
averag
million
pairedend
sequenc
read
gener
bal
sampl
microbi
sequenc
statist
pipelin
output
patient
describ
tabl
mng
identifi
seven
microb
found
standard
clinic
diagnost
demonstr
sensit
pathogen
detect
total
rnaseq
identifi
rna
virus
establish
pathogen
lung
rna
intermedi
five
dna
virus
uncertain
pulmonari
pathogen
dnaseq
identifi
genom
five
dna
virus
well
five
other
includ
cmv
associ
pneumon
mng
captur
entir
viral
genom
five
patient
averag
read
depth
shown
figur
bacteria
known
exist
contextu
either
pathogen
commens
includ
stenotrophomona
maltophilia
streptococcu
miti
corynebacterium
propinquum
identifi
genera
typic
consid
pathogen
specif
mng
could
assess
cohort
lack
patient
proven
noninfecti
respiratori
ill
loss
divers
within
respiratori
tract
microbi
commun
propos
ecolog
marker
infect
thu
evalu
alpha
divers
activ
replic
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
page
microb
identifi
rnaseq
use
sdi
found
subject
confirm
pathogen
significantli
lower
divers
rel
patient
microb
unlik
uncertain
pathogen
iqr
vs
iqr
figur
tabl
reduc
divers
also
observ
subject
confirm
potenti
new
pathogen
compar
togeth
without
iqr
vs
iqr
p
hypothes
gene
express
respiratori
fluid
obtain
site
infect
would
distinguish
patient
lrti
noninfecti
respiratori
diseas
test
idea
evalu
priori
select
gene
biomark
innat
adapt
immun
respons
use
total
normal
express
gene
given
suspect
betweensubject
immunolog
respons
heterogen
due
differ
infect
type
degre
immunolog
compromis
creat
composit
metric
base
sum
normal
gene
express
biomark
found
significantli
increas
express
patient
confirm
lrti
pathogen
versu
without
iqr
vs
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
page
proof
concept
studi
demonstr
mng
simultan
detect
pathogen
host
respons
hct
patient
acut
respiratori
ill
benchmark
convent
standard
care
test
perform
time
studi
enrol
mng
demonstr
sensit
microbi
detect
permit
identif
potenti
new
viral
bacteri
pathogen
six
subject
otherwis
neg
test
observ
presenc
respiratori
pathogen
character
increas
express
host
immun
respons
gene
lower
airway
microbi
divers
result
suggest
simultan
mng
detect
respiratori
pathogen
host
immunolog
respons
airway
microbiom
may
provid
complementari
data
could
inform
clinic
signific
detect
pathogen
amongst
case
neg
clinic
test
mng
identifi
six
patient
harbor
transcript
activ
microb
recogn
respiratori
pathogen
respect
virus
identifi
two
patient
hrva
identifi
three
patient
one
also
cultureposit
stenotrophomona
maltophilia
notabl
hrv
hcov
repres
multiplex
pcr
panel
use
studi
hospit
similar
limit
panel
still
use
mani
hospit
today
unlik
rapid
antigen
multiplex
pcr
assay
mng
limit
fix
number
prespecifi
target
panel
obviat
need
order
multipl
independ
diagnost
test
furthermor
mng
detect
entir
viral
genom
illustr
figur
attribut
enabl
genotyp
detect
resist
mutat
epidemiolog
track
diseas
outbreak
respect
previous
unidentifi
bacteri
pathogen
mng
detect
streptococcu
miti
oropharyng
microb
known
caus
bacteremia
acut
respiratori
distress
hct
recipi
potenti
pulmonari
pathogen
one
patient
corynebacterium
propriniquum
one
virul
corynebacterium
speci
associ
lrti
compris
major
microbi
transcript
anoth
subject
bal
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
fluid
patient
receiv
empir
vancomycin
activ
streptococcu
corynebacteria
spp
recov
acut
respiratori
ill
find
independ
confirm
genu
level
rrna
gene
sequenc
ten
patient
neg
convent
test
found
microb
unlik
uncertain
pathogen
notabl
patient
potenti
altern
explan
respiratori
symptom
one
patient
bacteremiasepsi
remain
nine
acut
andor
chronic
gvhd
underlin
import
noninfecti
alloreact
inflamm
posthct
pulmonari
complic
mng
identifi
sever
virus
dna
genom
howev
five
also
welldefin
evid
activ
replic
mark
detect
rna
transcript
hsv
human
papilloma
viru
torqu
teno
virus
ttv
ttv
commonli
detect
dna
viru
find
consist
prior
report
demonstr
increas
preval
presumpt
innocu
constitu
human
virom
immunosuppress
patient
herpesvirida
genom
dna
absenc
viral
transcript
identifi
five
patient
includ
cmv
hsv
ebv
one
subject
die
day
postbal
due
relaps
lymphoma
ebv
dna
detect
set
ebv
viremia
wu
polyoma
viru
detect
dna
sequenc
anoth
case
viru
associ
respiratori
infect
immunocompromis
patient
evid
support
role
pathogen
lack
cmv
identifi
viral
cultur
mng
one
subject
howev
find
consid
unrel
patient
respiratori
ill
treat
physician
notabl
cmv
detect
dnaseq
rna
transcript
identifi
suggest
may
repres
incident
carriag
oppos
transcript
activ
pathogen
patient
also
found
harbor
pseudomona
fluorescen
describ
colon
human
respiratori
tract
well
sever
taxa
repres
common
constitu
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
oropharyng
respiratori
microbiom
includ
rothia
prevotella
actinomyc
spp
detail
tabl
asymptomat
carriag
respiratori
pathogen
well
describ
establish
biomark
genuin
infect
critic
determin
whether
given
microbiolog
find
clinic
signific
find
suggest
respiratori
tract
microbi
divers
may
biomark
specif
found
patient
lrti
pathogen
significantli
lower
alpha
divers
versu
without
figur
tabl
presum
reflect
domin
activ
replic
pathogen
result
also
demonstr
mng
convent
method
identifi
clinic
signific
insignific
microb
emphas
need
assess
impact
given
microbiolog
find
context
patient
immunolog
respons
express
multigen
immun
respons
metric
significantli
increas
patient
confirm
respiratori
pathogen
rel
without
suggest
despit
signific
heterogen
state
immun
suppress
hct
recipi
still
exhibit
immunolog
biomark
activ
infect
figur
amongst
subject
potenti
new
pathogen
observ
two
three
hrva
posit
subject
demonstr
lowest
express
immun
respons
metric
remain
subject
coinfect
hrva
stenotrophomona
maltophilia
one
highest
valu
consist
prior
report
demonstr
hrv
induc
broad
rang
clinic
diseas
sever
viralbacteri
coinfect
increas
sever
diseas
amongst
subject
confirm
pathogen
patient
clinic
suspect
pneumon
notabl
outlier
term
reduc
immun
metric
express
elev
airway
divers
respiratori
pathogen
controversi
pair
mng
pathogen
data
demonstr
absenc
viral
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
page
transcript
detect
genom
dna
support
less
virul
role
patient
broadspectrum
antibiot
overus
frequent
driven
suspicion
occult
pathogen
miss
standard
diagnost
test
instanc
patient
whose
convent
test
result
highli
encourag
proofofconcept
studi
suggest
mani
rout
improv
first
studi
limit
rel
small
sampl
size
one
case
cultureposit
bacteri
lrti
fungal
infect
subject
clinic
diagnos
noninfecti
airway
diseas
futur
studi
larger
cohort
need
valid
sensit
specif
mng
lrti
diagnosi
popul
second
limit
sequenc
depth
yield
human
transcriptom
coverag
would
desir
robust
differenti
gene
express
analys
although
abl
rigor
evalu
composit
metric
immun
gene
futur
larger
studi
need
identifi
valid
gene
classifi
distinguish
lrti
noninfecti
airway
diseas
hct
recipi
leverag
continu
improv
metagenom
sequenc
expand
capabl
lrti
diagnost
hct
recipi
acut
respiratori
ill
demonstr
compar
current
microbi
diagnost
mng
greater
capac
detect
microb
abil
coupl
pathogen
detect
simultan
profil
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
page
host
respons
airway
microbiom
suggest
sever
way
futur
studi
may
improv
proofofconcept
studi
includ
valid
larger
prospect
cohort
hct
recipi
highrisk
popul
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
rpm
nt
x
z
nt
z
nr
improv
specif
microbi
assign
requir
microb
detect
nt
nr
databas
align
microb
z
nt
z
nr
greater
zero
bacteria
fungi
detect
rnaseq
also
detect
genom
sequenc
dnaseq
patient
microb
pass
requir
classifi
either
confirm
pathogen
new
potenti
pathogen
unlik
uncertain
pathogen
copyright
holder
preprint
peerreview
authorfund
tabl
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
authorfund
http
doi
biorxiv
preprint
